Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model.
Scabies is one of the commonest dermatological conditions globally; however it is a largely underexplored and truly neglected infectious disease. Foremost, improvement in the management of this public health burden is imperative. Current treatments with topical agents and/or oral ivermectin (IVM) ar...
Main Authors: | Charlotte Bernigaud, Fang Fang, Katja Fischer, Anne Lespine, Ludwig Serge Aho, Dominique Dreau, Andrew Kelly, Jean-François Sutra, Francis Moreau, Thomas Lilin, Françoise Botterel, Jacques Guillot, Olivier Chosidow |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-10-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC5061321?pdf=render |
Similar Items
-
Prospects for Moxidectin as a New Oral Treatment for Human Scabies.
by: Kate E Mounsey, et al.
Published: (2016-03-01) -
Relative neurotoxicity of ivermectin and moxidectin in Mdr1ab (-/-) mice and effects on mammalian GABA(A) channel activity.
by: Cécile Ménez, et al.
Published: (2012-01-01) -
High-dose ivermectin in malaria and other parasitic diseases: a new step in the development of a neglected drug
by: Chosidow Olivier, et al.
Published: (2018-01-01) -
The Management of Scabies in the 21st Century: Past, Advances and Potentials
by: Charlotte Bernigaud, et al.
Published: (2020-04-01) -
A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients
by: Alain Bousquet-Mélou, et al.
Published: (2021-05-01)